Analysts at Royal Bank Of Canada initiated coverage on shares of Merus N.V. (NASDAQ:MRUS) in a research note issued on Thursday, The Fly reports. The brokerage set an “outperform” rating on the biotechnology company’s stock.

Several other analysts have also commented on MRUS. ValuEngine raised shares of Merus N.V. from a “sell” rating to a “hold” rating in a research note on Saturday, May 20th. Wedbush reissued an “outperform” rating and set a $32.00 target price on shares of Merus N.V. in a research note on Tuesday, June 6th. Zacks Investment Research lowered shares of Merus N.V. from a “hold” rating to a “sell” rating in a research note on Wednesday, June 28th. Finally, Jefferies Group LLC reissued a “buy” rating and set a $31.00 target price on shares of Merus N.V. in a research note on Friday, July 14th. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. Merus N.V. presently has a consensus rating of “Buy” and a consensus target price of $31.33.

Shares of Merus N.V. (MRUS) traded up 0.0639% on Thursday, hitting $15.4999. The company had a trading volume of 5,939 shares. The company has a 50-day moving average of $15.95 and a 200 day moving average of $23.65. The stock’s market cap is $300.56 million. Merus N.V. has a 12 month low of $9.77 and a 12 month high of $29.75.

ILLEGAL ACTIVITY WARNING: This article was first reported by American Banking News and is owned by of American Banking News. If you are accessing this article on another publication, it was illegally copied and republished in violation of international copyright and trademark law. The original version of this article can be accessed at https://www.americanbankingnews.com/2017/09/14/royal-bank-of-canada-initiates-coverage-on-merus-n-v-mrus.html.

A number of hedge funds have recently added to or reduced their stakes in MRUS. Spark Investment Management LLC acquired a new stake in Merus N.V. during the first quarter valued at approximately $458,000. Renaissance Technologies LLC acquired a new stake in Merus N.V. during the first quarter valued at approximately $549,000. Victory Capital Management Inc. acquired a new stake in Merus N.V. during the first quarter valued at approximately $976,000. Iguana Healthcare Management LLC lifted its stake in Merus N.V. by 16.7% during the first quarter. Iguana Healthcare Management LLC now owns 175,000 shares of the biotechnology company’s stock valued at $4,268,000 after purchasing an additional 25,000 shares during the last quarter. Finally, Nationwide Fund Advisors lifted its stake in Merus N.V. by 13,206.9% during the first quarter. Nationwide Fund Advisors now owns 222,225 shares of the biotechnology company’s stock valued at $5,418,000 after purchasing an additional 220,555 shares during the last quarter. 32.16% of the stock is owned by institutional investors and hedge funds.

Merus N.V. Company Profile

The Fly

Receive News & Ratings for Merus N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merus N.V. and related companies with MarketBeat.com's FREE daily email newsletter.